These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 30654154)
1. Understanding attitudes and behaviors towards cell-free DNA-based noninvasive prenatal testing (NIPT): A survey of European health-care providers. Benachi A; Caffrey J; Calda P; Carreras E; Jani JC; Kilby MD; Klein HG; Rizzo G; Yaron Y Eur J Med Genet; 2020 Jan; 63(1):103616. PubMed ID: 30654154 [TBL] [Abstract][Full Text] [Related]
2. Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory. Togneri FS; Kilby MD; Young E; Court S; Williams D; Griffiths MJ; Allen SK Genet Res (Camb); 2019 Dec; 101():e11. PubMed ID: 31813398 [TBL] [Abstract][Full Text] [Related]
3. Obstetrical provider knowledge and attitudes towards cell-free DNA screening: results of a cross-sectional national survey. Chan WV; Johnson JA; Wilson RD; Metcalfe A BMC Pregnancy Childbirth; 2018 Jan; 18(1):40. PubMed ID: 29361931 [TBL] [Abstract][Full Text] [Related]
4. Current use of noninvasive prenatal testing in Europe, Australia and the USA: A graphical presentation. Gadsbøll K; Petersen OB; Gatinois V; Strange H; Jacobsson B; Wapner R; Vermeesch JR; ; Vogel I Acta Obstet Gynecol Scand; 2020 Jun; 99(6):722-730. PubMed ID: 32176318 [TBL] [Abstract][Full Text] [Related]
5. Survey of US obstetrician opinions regarding NIPT use in general practice: implementation and barriers. Brewer J; Demers L; Musci T J Matern Fetal Neonatal Med; 2017 Aug; 30(15):1793-1796. PubMed ID: 27588713 [TBL] [Abstract][Full Text] [Related]
6. Peripheral Blood Microbiome Analysis via Noninvasive Prenatal Testing Reveals the Complexity of Circulating Microbial Cell-Free DNA. Tong X; Yu X; Du Y; Su F; Liu Y; Li H; Liu Y; Mu K; Liu Q; Li H; Zhu J; Xu H; Xiao F; Li Y Microbiol Spectr; 2022 Jun; 10(3):e0041422. PubMed ID: 35608350 [TBL] [Abstract][Full Text] [Related]
7. Have we done our last amniocentesis? Updates on cell-free DNA for Down syndrome screening. Gray KJ; Wilkins-Haug LE Pediatr Radiol; 2018 Apr; 48(4):461-470. PubMed ID: 29550862 [TBL] [Abstract][Full Text] [Related]
8. "I think we've got too many tests!": Prenatal providers' reflections on ethical and clinical challenges in the practice integration of cell-free DNA screening. Gammon BL; Kraft SA; Michie M; Allyse M Ethics Med Public Health; 2016; 2(3):334-342. PubMed ID: 28180146 [TBL] [Abstract][Full Text] [Related]
9. Causes of aberrant non-invasive prenatal testing for aneuploidy: A systematic review. Samura O; Okamoto A Taiwan J Obstet Gynecol; 2020 Jan; 59(1):16-20. PubMed ID: 32039788 [TBL] [Abstract][Full Text] [Related]
10. The Combining Effects of Cell-Free Circulating Tumor DNA of Breast Tumor to the Noninvasive Prenatal Testing Results: A Simulating Investigation. Cai YH; Yao GY; Chen LJ; Gan HY; Ye CS; Yang XX DNA Cell Biol; 2018 Jul; 37(7):626-633. PubMed ID: 29957029 [TBL] [Abstract][Full Text] [Related]
11. Noninvasive prenatal testing. Lo JO; Cori D F; Norton ME; Caughey AB Obstet Gynecol Surv; 2014 Feb; 69(2):89-99. PubMed ID: 25112487 [TBL] [Abstract][Full Text] [Related]
12. Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions/microduplications in a cohort of 8141 single pregnancies. Hu H; Wang L; Wu J; Zhou P; Fu J; Sun J; Cai W; Liu H; Yang Y Hum Genomics; 2019 Mar; 13(1):14. PubMed ID: 30871627 [TBL] [Abstract][Full Text] [Related]
13. Maternal Plasma DNA and RNA Sequencing for Prenatal Testing. Tamminga S; van Maarle M; Henneman L; Oudejans CB; Cornel MC; Sistermans EA Adv Clin Chem; 2016; 74():63-102. PubMed ID: 27117661 [TBL] [Abstract][Full Text] [Related]
14. Improving the accuracy of noninvasive prenatal testing through size-selection between fetal and maternal cfDNA. Kwon HJ; Yun S; Joo J; Park D; Do WJ; Lee S; Lee MS Prenat Diagn; 2023 Dec; 43(13):1581-1592. PubMed ID: 37975672 [TBL] [Abstract][Full Text] [Related]
15. A proof-of-concept study on the effects of low total cfDNA content and solutions to increase the NIPT trisomy 21 detection rate. Du Y; Chen A; Yang R; Zhou T; Zhou Q; Yang L; Wang J; Hong Y; Chen C; Wan Q; Yang L; Chen Y J Clin Lab Anal; 2020 Feb; 34(2):e23035. PubMed ID: 31568605 [TBL] [Abstract][Full Text] [Related]
16. The fragmentation patterns of maternal plasma cell-free DNA and its applications in non-invasive prenatal testing. Pan M; Chen P; Lu J; Liu Z; Jia E; Ge Q Prenat Diagn; 2020 Jul; 40(8):911-917. PubMed ID: 32147843 [TBL] [Abstract][Full Text] [Related]
17. Sequencing shorter cfDNA fragments improves the fetal DNA fraction in noninvasive prenatal testing. Qiao L; Yu B; Liang Y; Zhang C; Wu X; Xue Y; Shen C; He Q; Lu J; Xiang J; Li H; Zheng Q; Wang T Am J Obstet Gynecol; 2019 Oct; 221(4):345.e1-345.e11. PubMed ID: 31125545 [TBL] [Abstract][Full Text] [Related]
18. Potentially effective method for fetal gender determination by noninvasive prenatal testing for X-linked disease. Noda Y; Kato T; Kato A; Nishizawa H; Miyazaki J; Ito M; Terasawa S; Sekiya T; Fujii T; Kurahashi H Congenit Anom (Kyoto); 2019 May; 59(3):88-92. PubMed ID: 29926512 [TBL] [Abstract][Full Text] [Related]
19. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting. Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470 [TBL] [Abstract][Full Text] [Related]
20. cfDNA deconvolution via NIPT of a pregnant woman after bone marrow transplant and donor egg IVF. Zhu J; Hui F; Mao X; Zhang S; Qi H; Du Y Hum Genomics; 2021 Feb; 15(1):14. PubMed ID: 33622405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]